More serious but rarer side effects include pancreatitis (uncertain risk increase), gallbladder disease (increased risk with rapid weight loss), hypoglycemia when combined with other diabetes medications, and injection site reactions
Unfortunately, it has been difficult to determine the effects of GLP-1 treatment on human beta cell mass, because it is hard to measure directly how many beta cells we have without taking out some of the pancreas
By working together, you can develop a treatment plan that minimizes side effects and maximizes the benefits of this medication
Its relevance in humans is uncertain
Certificates of Analysis (COA) and Material Safety Data Sheets (MSDS) are available upon request to support institutional compliance across EU jurisdictions
Key takeaways There are currently three FDA-approved oral GLP-1 medications: Rybelsus, Wegovy pill, and Foundayo